Updated Jul 16, 2026
Green Kevin Dennis has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $480K.
Kevin Dennis Green is associated with Cerus Corporation, a biomedical company focused on blood safety and pathogen reduction technologies. Specific details regarding his role or contributions to the company are not widely available.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | CERS | CERUS CORP | S — Open-market sale | 33.7K | $2.94 | $99K |
| 2026-07-02 | CERS | CERUS CORP | A — Grant or award | 63.6K | $0.00 | |
| 2026-04-03 | CERS | CERUS CORP | A — Grant or award | 200.0K | $0.00 | |
| 2026-03-16 | CERS | CERUS CORP | S — Open-market sale [10b5-1] | 127.5K | $1.66 | $211K |
| 2026-03-10 | CERS | CERUS CORP | S — Open-market sale [10b5-1] | 27.8K | $2.01 | $56K |
| 2026-03-10 | CERS | CERUS CORP | S — Open-market sale [10b5-1] | 55.2K | $2.06 | $114K |
| 2026-03-10 | CERS | CERUS CORP | A — Grant or award [10b5-1] | 63.9K | $0.00 | |
| 2026-03-05 | CERS | CERUS CORP | A — Grant or award | 300.0K | $0.00 |
Kevin Dennis Green is associated with Cerus Corporation, a biomedical company focused on blood safety and pathogen reduction technologies. Specific details regarding his role or contributions to the company are not widely available.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($480K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Green Kevin Dennis profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.